1.Alteration of Cognitive Function in Mild Traumatic Brain Injury Patients Grouped by Subjective Depression.
Heesung HWANG ; Kyoung Sae NA ; Shin Gyeom KIM ; Soyoung Irene LEE ; Han Yong JUNG
Journal of Korean Neuropsychiatric Association 2012;51(5):300-305
OBJECTIVES: To examine the association of subjective depressive symptoms and cognitive dysfunction in patients with mild traumatic brain injury (mTBI). METHODS: 36 patients with mTBI without structural abnormality in the brain imaging study were recruited. Participants were subdivided into two groups by a cutoff score of 70T in the Beck Depression Inventory (BDI). Cognitive functions including intelligence, memory, and executive function were significantly lower in the <70T group compared to the > or =70T group. In addition, BDI scores were negatively correlated with performances in most of the neuropsychological tests. RESULTS: Patients group who scored 70T or more in the BDI showed significantly lower scores in most items of the neuropsychological tests. CONCLUSION: High subjective depression is associated with low neuropsychological performance in mTBI.
Brain Injuries
;
Depression
;
Executive Function
;
Humans
;
Intelligence
;
Memory
;
Neuroimaging
2.Venlafaxine-Induced Acute Toxic Hepatitis.
Kyeong Sae NA ; Heesung HWANG ; Shin Gyeom KIM ; Soyoung Irene LEE ; Han Yong JUNG
Journal of the Korean Society of Biological Psychiatry 2011;18(3):159-162
Venlafaxine is among the most widely prescribed antidepressants. It is extensively metabolized to O-desmethylvenlafaxine via cytochrome P450 (CYP) 2D6. We report a case of acute toxic hepatitis resulting from venlafaxine in a 54-year-old woman with pain disorder. During venlafaxine treatment, laboratory tests revealed elevated liver enzymes with a maximum of 169 IU/L for aspartate transaminase (AST) and 166 IU/L for alanine transaminase (ALT). AST and ALT levels returned to normal after 6 days of discontinuation of venlafaxine. The patient was finally diagnosed with acute toxic hepatitis through liver biopsy. This case indicates the importance that clinicians should be aware of the hepatotoxicity of venlafaxine in practice.
Alanine Transaminase
;
Antidepressive Agents
;
Aspartate Aminotransferases
;
Biopsy
;
Cyclohexanols
;
Cytochrome P-450 Enzyme System
;
Drug Toxicity
;
Drug-Induced Liver Injury
;
Female
;
Humans
;
Liver
;
Middle Aged
;
Somatoform Disorders
;
Desvenlafaxine Succinate
;
Venlafaxine Hydrochloride